Treatment of Physician's Choice Clinical Trials

4 actively recruiting trials across 2 locations

Pipeline

Phase 2: 1Phase 3: 2

Top Sponsors

University of California, San Diego1
Peking Union Medical College Hospital1
Fudan University1
BriaCell Therapeutics Corporation1

Indications

Breast Cancer4
Cancer4
End Stage Cancer1
Metastatic Breast Cancer1
Breast Cancer, Metastatic1

Other2 trials

Chemotherapy Omission in ER+/HER2- Breast Cancer With 1-3 Positive Lymph Nodes Receiving Extended Adjuvant Abemaciclib

Phase 3

Pyrotinib Plus Capecitabine for Adjuvant Treatment of HER2 Positive Early-stage Breast Cancer

Phoenix, Arizona1 trial

Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.

Mayo Clinic-Comprehensive Cancer Center-Breast Clinic

Phase 3

La Jolla, California1 trial

Artificial Intelligence and Machine Learning to Guide CDK4/6 Inhibitor Rechallenge in Breast Cancer.

University of California, San Diego

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.